ZUMRF yields 4000.00% · JNJ yields 2.13%● Live data
📍 ZUMRF pulled ahead of the other in Year 1
Combined, ZUMRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ZUMRF + JNJ for your $10,000?
ZoomerMedia Limited operates as a multimedia company in Canada. The company operates through five segments: Television, Radio, Print, Royalty, and Other Operations. It is involved in the business of television, radio, magazine, Internet, conferences, and trade shows primarily for the 45 plus age group. The company's television properties include Vision TV, a multi-cultural and multi-faith specialty television service; ONE TV, which offers fitness, healthy living, and entertainment programs; JoyTV and Faith TV, channels for broadcasting Christian and local programming; and TVL Channel 5, a linear television channel guide available to households. It also operates various radio stations, such as CFMZ-FM Toronto and CFMX-FM Cobourg; CFMO-FM Collingwood; CFZM-AM 740 Toronto and CFZM-FM 96.7FM Toronto Zoomer Radio; and Toronto's Timeless Hits station. In addition, the company publishes Zoomer magazine; and On The Bay Magazine, a regional lifestyle magazine published quarterly for the 20 towns and villages of Southern Georgian By, Ontario, as well as Tonic magazine, a regional health and wellness magazine published for every two months and distributed in Toronto. Further, it provides online content services targeting the 45plus age group primarily through EverythingZoomer.com and blogTO.com, as well as CARP.ca, VisionTV.ca, ZoomerRadio.ca, and ClassicalFM.ca. Additionally, the company produces ZoomerShows, an annual consumer shows directed to the Zoomer demographic; and ideaCity, an annual Canadian conference. ZoomerMedia Limited was founded in 2008 and is based in Toronto, Canada.
Full ZUMRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.